Selected research
Market Outlook & Growth Opportunities
Global Pharmaceutical Outsourcing Analytical Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Pharmaceutical Outsourcing Analytical Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pharmaceutical Outsourcing Analytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Outsourcing Analytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Outsourcing Analytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pharmaceutical Outsourcing Analytical Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pharmaceutical Outsourcing Analytical Testing market include Merck, Recro Gainesville, Recipharm, Quotient Sciences, Metrics Contract Services, Frontida Biopharm, Frontage, ENCO Pharmaceutical Development and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pharmaceutical Outsourcing Analytical Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Outsourcing Analytical Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Outsourcing Analytical Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Outsourcing Analytical Testing market.
Pharmaceutical Outsourcing Analytical Testing Segment by Company
Merck
Recro Gainesville
Recipharm
Quotient Sciences
Metrics Contract Services
Frontida Biopharm
Frontage
ENCO Pharmaceutical Development
Catalent
Aztech Sciences
Ascendia Pharmaceuticals
ARL Bio Pharma
Alcami
Pharmaceutical Outsourcing Analytical Testing Segment by Type
Stability Testing
Bioanalytical Testing
Method Development & Validation
Others
Pharmaceutical Outsourcing Analytical Testing Segment by Application
Small & Medium Enterprise
Large Enterprise
Pharmaceutical Outsourcing Analytical Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Pharmaceutical Outsourcing Analytical Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmaceutical Outsourcing Analytical Testing key companies, revenue, market share, and recent developments.
3. To split the Pharmaceutical Outsourcing Analytical Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmaceutical Outsourcing Analytical Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmaceutical Outsourcing Analytical Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmaceutical Outsourcing Analytical Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Outsourcing Analytical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Outsourcing Analytical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Outsourcing Analytical Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Outsourcing Analytical Testing industry.
Chapter 3: Detailed analysis of Pharmaceutical Outsourcing Analytical Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmaceutical Outsourcing Analytical Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmaceutical Outsourcing Analytical Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Stability Testing
- Bioanalytical Testing
- Method Development & Validation
- Others
Applications
- Small & Medium Enterprise
- Large Enterprise
Companies covered
- Merck
- Recro Gainesville
- Recipharm
- Quotient Sciences
- Metrics Contract Services
- Frontida Biopharm
- Frontage
- ENCO Pharmaceutical Development
- Catalent
- Aztech Sciences
- Ascendia Pharmaceuticals
- ARL Bio Pharma
- Alcami
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Outsourcing Analytical Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Outsourcing Analytical Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Outsourcing Analytical Testing Market Dynamics
- 2.1 Pharmaceutical Outsourcing Analytical Testing Industry Trends
- 2.2 Pharmaceutical Outsourcing Analytical Testing Industry Drivers
- 2.3 Pharmaceutical Outsourcing Analytical Testing Industry Opportunities and Challenges
- 2.4 Pharmaceutical Outsourcing Analytical Testing Industry Restraints
3 Pharmaceutical Outsourcing Analytical Testing Market by Company
- 3.1 Global Pharmaceutical Outsourcing Analytical Testing Company Revenue Ranking in 2025
- 3.2 Global Pharmaceutical Outsourcing Analytical Testing Revenue by Company (2021-2026)
- 3.3 Global Pharmaceutical Outsourcing Analytical Testing Company Ranking (2024-2026)
- 3.4 Global Pharmaceutical Outsourcing Analytical Testing Company Manufacturing Base and Headquarters
- 3.5 Global Pharmaceutical Outsourcing Analytical Testing Company Product Type and Application
- 3.6 Global Pharmaceutical Outsourcing Analytical Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmaceutical Outsourcing Analytical Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmaceutical Outsourcing Analytical Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Outsourcing Analytical Testing Market by Type
- 4.1 Pharmaceutical Outsourcing Analytical Testing Type Introduction
- 4.1.1 Stability Testing
- 4.1.2 Bioanalytical Testing
- 4.1.3 Method Development & Validation
- 4.1.4 Others
- 4.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Type
- 4.2.1 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Outsourcing Analytical Testing Market by Application
- 5.1 Pharmaceutical Outsourcing Analytical Testing Application Introduction
- 5.1.1 Small & Medium Enterprise
- 5.1.2 Large Enterprise
- 5.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Application
- 5.2.1 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Outsourcing Analytical Testing Regional Value Analysis
- 6.1 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Outsourcing Analytical Testing Sales Value (2021-2032)
- 6.3.2 North America Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Outsourcing Analytical Testing Sales Value (2021-2032)
- 6.4.2 Europe Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmaceutical Outsourcing Analytical Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmaceutical Outsourcing Analytical Testing Sales Value (2021-2032)
- 6.6.2 South America Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmaceutical Outsourcing Analytical Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Outsourcing Analytical Testing Country-level Value Analysis
- 7.1 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmaceutical Outsourcing Analytical Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmaceutical Outsourcing Analytical Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmaceutical Outsourcing Analytical Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Recro Gainesville
- 8.2.1 Recro Gainesville Company Information
- 8.2.2 Recro Gainesville Business Overview
- 8.2.3 Recro Gainesville Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 Recro Gainesville Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.2.5 Recro Gainesville Recent Developments
- 8.3 Recipharm
- 8.3.1 Recipharm Company Information
- 8.3.2 Recipharm Business Overview
- 8.3.3 Recipharm Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 Recipharm Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.3.5 Recipharm Recent Developments
- 8.4 Quotient Sciences
- 8.4.1 Quotient Sciences Company Information
- 8.4.2 Quotient Sciences Business Overview
- 8.4.3 Quotient Sciences Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 Quotient Sciences Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.4.5 Quotient Sciences Recent Developments
- 8.5 Metrics Contract Services
- 8.5.1 Metrics Contract Services Company Information
- 8.5.2 Metrics Contract Services Business Overview
- 8.5.3 Metrics Contract Services Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 Metrics Contract Services Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.5.5 Metrics Contract Services Recent Developments
- 8.6 Frontida Biopharm
- 8.6.1 Frontida Biopharm Company Information
- 8.6.2 Frontida Biopharm Business Overview
- 8.6.3 Frontida Biopharm Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 Frontida Biopharm Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.6.5 Frontida Biopharm Recent Developments
- 8.7 Frontage
- 8.7.1 Frontage Company Information
- 8.7.2 Frontage Business Overview
- 8.7.3 Frontage Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 Frontage Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.7.5 Frontage Recent Developments
- 8.8 ENCO Pharmaceutical Development
- 8.8.1 ENCO Pharmaceutical Development Company Information
- 8.8.2 ENCO Pharmaceutical Development Business Overview
- 8.8.3 ENCO Pharmaceutical Development Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.8.4 ENCO Pharmaceutical Development Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.8.5 ENCO Pharmaceutical Development Recent Developments
- 8.9 Catalent
- 8.9.1 Catalent Company Information
- 8.9.2 Catalent Business Overview
- 8.9.3 Catalent Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.9.4 Catalent Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.9.5 Catalent Recent Developments
- 8.10 Aztech Sciences
- 8.10.1 Aztech Sciences Company Information
- 8.10.2 Aztech Sciences Business Overview
- 8.10.3 Aztech Sciences Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.10.4 Aztech Sciences Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.10.5 Aztech Sciences Recent Developments
- 8.11 Ascendia Pharmaceuticals
- 8.11.1 Ascendia Pharmaceuticals Company Information
- 8.11.2 Ascendia Pharmaceuticals Business Overview
- 8.11.3 Ascendia Pharmaceuticals Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.11.4 Ascendia Pharmaceuticals Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.11.5 Ascendia Pharmaceuticals Recent Developments
- 8.12 ARL Bio Pharma
- 8.12.1 ARL Bio Pharma Company Information
- 8.12.2 ARL Bio Pharma Business Overview
- 8.12.3 ARL Bio Pharma Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.12.4 ARL Bio Pharma Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.12.5 ARL Bio Pharma Recent Developments
- 8.13 Alcami
- 8.13.1 Alcami Company Information
- 8.13.2 Alcami Business Overview
- 8.13.3 Alcami Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 8.13.4 Alcami Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 8.13.5 Alcami Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst